response from Lawson Wilkins

Pediatric Endocrine Society


February 25, 2010

Ellen K. Feder, Ph.D. (corresponding author)

Associate Professor and Acting Chair

Department of Philosophy and Religion

American University

4400 Massachusetts Ave., NW

Washington, DC 20018-8056

Alice Dreger, Ph.D.

Professor of Clinical Medical Humanities and Bioethics

Feinberg School of Medicine

Northwestern University

Dear Drs. Feder and Dreger:

The Lawson Wilkins Pediatric Endocrine Society Board of Directors have read your letter of 2-22-2010 and have discussed the concerns voiced. Our Society is aware of the therapeutic controversy related to prenatal dexamethasone therapy. Recently, the Lawson Wilkins Pediatric Endocrine Society has participated in the development of a guidelines consensus statement regarding the treatment of children with congenital virilizing adrenal hyperplasia. One section of that document concerns pre-natal therapy of mothers carrying a potentially affected fetus. That article is presently under scientific review and will be published in a peer reviewed journal and become publically [sic] available in the next few months.

Yours sincerely,

Dorothy Becker, MD